{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:33:54Z","timestamp":1787614434220,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.carres.2025.109580","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T06:41:23Z","timestamp":1749710483000},"page":"109580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Polysaccharides coated on mesoporous silica nanoparticles inhibit the inflammatory response for the treatment of sepsis"],"prefix":"10.1016","volume":"555","author":[{"given":"Sha","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carres.2025.109580_bib1","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00134-024-07650-x","article-title":"Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations","volume":"50","author":"Barton","year":"2024","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.carres.2025.109580_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s15010-024-02388-6","article-title":"Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features","volume":"53","author":"Genseke","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.carres.2025.109580_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12951-023-01913-3","article-title":"Bioengineered stem cell membrane functionalized nanoparticles combine anti-inflammatory and antimicrobial properties for sepsis treatment","volume":"21","author":"Lu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.carres.2025.109580_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13054-015-0953-2","article-title":"Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge","volume":"19","author":"Honore","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.carres.2025.109580_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200544050-00007","article-title":"Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis","volume":"44","author":"Novelli","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.carres.2025.109580_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616881","article-title":"A new method for optimizing sepsis therapy by nivolumab and meropenem combination: importance of early intervention and CTL reinvigoration rate as a response marker","volume":"12","author":"Gillis","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.carres.2025.109580_bib7","article-title":"Optimized dosing regimens of meropenem in septic children receiving extracorporeal life support","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.carres.2025.109580_bib8","article-title":"Evaluating the influence MRSA Co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.carres.2025.109580_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/acsinfecdis.8b00011","article-title":"Vancomycin analogue restores meropenem activity against NDM-1 gram-negative pathogens","volume":"4","author":"Yarlagadda","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.carres.2025.109580_bib10","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/AAC.01582-09","article-title":"Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration","volume":"54","author":"Bilgrami","year":"2010","journal-title":"AAC (Antimicrob. Agents Chemother.)"},{"key":"10.1016\/j.carres.2025.109580_bib11","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1097\/PCC.0000000000003698","article-title":"Subtherapeutic meropenem antibiotic exposure in children with septic shock assessed by noncompartmental pharmacokinetic analysis in a prospective dataset","volume":"26","author":"Bradley","year":"2025","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.carres.2025.109580_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cid\/ciy069","article-title":"Raising the stakes: loss of efflux pump regulation decreases meropenem susceptibility in burkholderia pseudomallei","volume":"67","author":"Sarovich","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.carres.2025.109580_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2022.126132","article-title":"Multifunctional mesoporous silica-based nanocomposites: synthesis and biomedical applications","volume":"285","author":"Noreen","year":"2022","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.carres.2025.109580_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107352","article-title":"Physiologically-based pharmacokinetic modelling in sepsis: a tool to elucidate how pathophysiology affects meropenem pharmacokinetics","volume":"64","author":"Bahnasawy","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.carres.2025.109580_bib15","doi-asserted-by":"crossref","first-page":"18609","DOI":"10.1021\/acsami.7b05163","article-title":"In situ growth of mesoporous silica with drugs on Titanium surface and its biomedical applications","volume":"9","author":"Wan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.carres.2025.109580_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125394","article-title":"Variable pore size of mesoporous silica in improving physical stability and oral bioavailability of insoluble drugs","volume":"674","author":"Qi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.carres.2025.109580_bib17","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/molecules22112020","article-title":"Inkjet Printing of drug-loaded mesoporous silica nanoparticles\u2014a platform for drug development","volume":"22","author":"Wickstr\u00f6m","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.carres.2025.109580_bib18","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s13346-023-01326-7","article-title":"Enlarged pore of worm mesoporous silica nanoparticles improves anti-inflammatory drug absorption","volume":"13","author":"Ou","year":"2023","journal-title":"Drug Deliv Transl Re"},{"key":"10.1016\/j.carres.2025.109580_bib19","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acsbiomaterials.3c00278","article-title":"Alginate-based oral delivery systems to enhance protection, release, and absorption of catalase","volume":"9","author":"Farid","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.carres.2025.109580_bib20","article-title":"P-1114. Comparative in vitro microbiologic study of two plant-based wound ointments","volume":"12","author":"Truong","year":"2025","journal-title":"Open Forum Infect Di"},{"key":"10.1016\/j.carres.2025.109580_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jop.1992.8.59","article-title":"The effect of some macromolecular ionic complexes on the pharmacokinetics and -dynamics of ocular cyclopentolate in rabbits","volume":"8","author":"Huupponen","year":"1992","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.carres.2025.109580_bib22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fmicb.2017.01999","article-title":"Caprylic and polygalacturonic acid combinations for eradication of microbial organisms embedded in biofilm","volume":"8","author":"Rosenblatt","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.carres.2025.109580_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/pharmaceutics14010104","article-title":"Quercetin liposomal nanoformulation for ischemia and reperfusion injury treatment","volume":"14","author":"Ferreira-Silva","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.carres.2025.109580_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2024.05.028","article-title":"Quercetin-loaded human umbilical cord mesenchymal stem cell-derived sEVs for spinal cord injury recovery","volume":"552","author":"Yang","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.carres.2025.109580_bib25","doi-asserted-by":"crossref","DOI":"10.1063\/5.0247728","article-title":"Enhanced precise therapy of ROS-sensitive dual-layer shell nanoparticles loading quercetin on DSS-induced ulcerative colitis mice","volume":"13","author":"Bai","year":"2025","journal-title":"APL Mater."},{"key":"10.1016\/j.carres.2025.109580_bib26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.molpharmaceut.0c01245","article-title":"Smart responsive quercetin-conjugated glycol chitosan prodrug micelles for treatment of inflammatory bowel diseases","volume":"18","author":"Shen","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.carres.2025.109580_bib27","article-title":"Multi-targeted nanogel drug delivery system alleviates neuroinflammation and promotes spinal cord injury repair","volume":"31","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"}],"container-title":["Carbohydrate Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000862152500206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000862152500206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:51:09Z","timestamp":1750294269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000862152500206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"alternative-id":["S000862152500206X"],"URL":"https:\/\/doi.org\/10.1016\/j.carres.2025.109580","relation":{},"ISSN":["0008-6215"],"issn-type":[{"value":"0008-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysaccharides coated on mesoporous silica nanoparticles inhibit the inflammatory response for the treatment of sepsis","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carres.2025.109580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109580"}}